Table of Contents
Preface
Chapter 1. Evolving Molecular Biology, Targeted Therapeutics and Neurocognitive Deficits in Neurofibromatosis 1
(Sumit Gupta, MD, Department of Pediatrics, MD Anderson Cancer Center, Houston, Texas, US; Ruby Siada, BS, Mayo Clinic Alix School of Medicine, Rochester, Minnesota, US; Jonathan D. Schwartz, DO, MPH, Department of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, US; David J. Daniels, MD, PhD, Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, US; Peter L. Stavinoha, PhD, ABBP, Department of Pediatrics, MD Anderson Cancer Center, Houston, Texas, US and Soumen Khatua, MD, Department of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, US)
Chapter 2. Gastrointestinal Stromal Tumors Associated with Neurofibromatosis Type 1
(Adil Menon, MD, MS Department of Pathology,Northwestern University,
Evanston, Illinois, USA and Richard A. Prayson, MD, Med Case Western Reserve School of Medicine and the Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, USA)
Chapter 3. Juvenile Myelomonocytic Leukemia in the Context of Neurofibromatosis Type 1
(Derek M. Loneman, Howard J. Meyerson and Richard A. Prayson – Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, US, et al.)
Chapter 4. Emerging Molecular Approaches to the Early Diagnosis of Neurofibromatosis Type 1
(Stevephen Hung and Richard A. Prayson – Case Western Reserve University School of Medicine and Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, US)
Chapter 5. Focal Cortical Dysplasia in Neurofibromatosis Type 1
(Richard A. Prayson – Cleveland Clinic, Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, US)
Index
